Humanigen Inc (HGENQ)

[cowtown jay]

Humanigen being a legitimate company, with progress being made, potential for more success, and value in our R&D, does distinguish us from similarly-situated companies.

But the threat we face is very real. Big Pharma needs to fight for their revenue dollars, and they fully leverage their influence over regulatory agencies to deny our authorization, and preclude government stockpiling of lenzilumab.

Half a dozen, or so, of my highlighted posts I shared on Twitter, mention the recall of our loaned shares. That would not be possible unless management was able to accumulate shares without that being detected. Hence, the design of our share structure. But when the loaned shares are recalled, it will show the market management's conviction of faith in the company, and that, in itself will entice buying. Of course, the real buying pressure will come from short sellers having to buy the shares they borrowed and sold short. Spoiler alert, there just won't be enough shares, which is why I added sell orders at $150 and $250, to go along with my existing sell orders at $100 and $200, with three sell orders below $100.

Our previous short squeeze was the result of just a share recall, with no regulatory approvals as an added buying incentive. But I think Dale and Durrant are trying to secure either a CMML or covid approval.

But you are right to be cautious, as am I, and as we all should be. This cabal of Big Pharma influence over a captured regulatory system is very powerful. I'm hoping we get an approval from Australia, and maybe even the UK.